L’avis intitulé « Vaccin antigrippal INFLUVAC : transition du vaccin antigrippal INFLUVAC, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
20/12/2024
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
Kzqg781s1r5u8Pav